Scenarios that move ARQT

Arcutis Biotherapeutics, Inc. - Common stock

Scenarios that move ARQT: 1 analysis, 0 positive, 1 negative.

  1. · Oruka Therapeutics reports positive week 28 ORKA-001 trial data — ▼ · impact -10 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing